Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.45 CAD | -2.00% | -0.81% | +122.73% |
22/04 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |
01/04 | Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 167M 123M 10.22B |
---|---|---|---|---|---|
Net income 2024 * | -26M -19.07M -1.59B | Net income 2025 * | -28M -20.54M -1.71B | EV / Sales 2024 * | - |
Net cash position 2024 * | 18.78M 13.78M 1.15B | Net cash position 2025 * | 13.62M 9.99M 832M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.45
x | P/E ratio 2025 * |
-6.45
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.43% |
1 day | -2.00% | ||
1 week | -0.81% | ||
Current month | +0.82% | ||
1 month | +0.82% | ||
3 months | +44.12% | ||
6 months | +113.04% | ||
Current year | +122.73% |
Managers | Title | Age | Since |
---|---|---|---|
David Elsley
FOU | Founder | - | 19/17/19 |
Director of Finance/CFO | - | 16/18/16 | |
Kelly Narine
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsley
FOU | Founder | - | 19/17/19 |
Jennifer Chao
BRD | Director/Board Member | 54 | 15/22/15 |
Michael Willner
BRD | Director/Board Member | 57 | 07/21/07 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 2.45 | -2.00% | 29,743 |
25/24/25 | 2.5 | +4.17% | 58,920 |
24/24/24 | 2.4 | -3.61% | 42,575 |
23/24/23 | 2.49 | +2.05% | 74,952 |
22/24/22 | 2.44 | -1.21% | 68,966 |
Delayed Quote Toronto S.E., April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+122.73% | 122M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CRDL Stock